SDMHF
Price
$201.50
Change
+$2.30 (+1.15%)
Updated
Dec 17 closing price
SNN
Price
$24.90
Change
-$0.54 (-2.12%)
Updated
Dec 18, 04:59 PM (EDT)
68 days until earnings call
Ad is loading...

SDMHF vs SNN

Header iconSDMHF vs SNN Comparison
Open Charts SDMHF vs SNNBanner chart's image
Sartorius Stedim Biotech
Price$201.50
Change+$2.30 (+1.15%)
Volume$1.22K
CapitalizationN/A
Smith & Nephew
Price$24.90
Change-$0.54 (-2.12%)
Volume$2.33K
CapitalizationN/A
SDMHF vs SNN Comparison Chart
Loading...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SDMHF vs. SNN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SDMHF is a Buy and SNN is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SDMHF: $201.50 vs. SNN: $24.89)
Brand notoriety: SDMHF and SNN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SDMHF: 1% vs. SNN: 62%
Market capitalization -- SDMHF: $28.9B vs. SNN: $10.95B
SDMHF [@Medical Specialties] is valued at $28.9B. SNN’s [@Medical Specialties] market capitalization is $10.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SDMHF’s FA Score shows that 1 FA rating(s) are green whileSNN’s FA Score has 1 green FA rating(s).

  • SDMHF’s FA Score: 1 green, 4 red.
  • SNN’s FA Score: 1 green, 4 red.
According to our system of comparison, both SDMHF and SNN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SDMHF’s TA Score shows that 3 TA indicator(s) are bullish while SNN’s TA Score has 5 bullish TA indicator(s).

  • SDMHF’s TA Score: 3 bullish, 4 bearish.
  • SNN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SNN is a better buy in the short-term than SDMHF.

Price Growth

SDMHF (@Medical Specialties) experienced а +1.15% price change this week, while SNN (@Medical Specialties) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.45%. For the same industry, the average monthly price growth was +1.34%, and the average quarterly price growth was -1.01%.

Reported Earning Dates

SNN is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-4.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDMHF($28.9B) has a higher market cap than SNN($10.9B). SNN has higher P/E ratio than SDMHF: SNN (40.76) vs SDMHF (35.84). SNN YTD gains are higher at: -6.171 vs. SDMHF (-23.602). SDMHF has higher annual earnings (EBITDA): 1.16B vs. SNN (956M). SNN has more cash in the bank: 302M vs. SDMHF (113M). SDMHF has less debt than SNN: SDMHF (1.31B) vs SNN (3.08B). SNN has higher revenues than SDMHF: SNN (5.55B) vs SDMHF (3.36B).
SDMHFSNNSDMHF / SNN
Capitalization28.9B10.9B265%
EBITDA1.16B956M121%
Gain YTD-23.602-6.171382%
P/E Ratio35.8440.7688%
Revenue3.36B5.55B60%
Total Cash113M302M37%
Total Debt1.31B3.08B42%
FUNDAMENTALS RATINGS
SDMHF vs SNN: Fundamental Ratings
SDMHF
SNN
OUTLOOK RATING
1..100
1769
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
8294
PRICE GROWTH RATING
1..100
5359
P/E GROWTH RATING
1..100
1791
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (5) in the Medical Specialties industry is significantly better than the same rating for SDMHF (81) in the null industry. This means that SNN’s stock grew significantly faster than SDMHF’s over the last 12 months.

SDMHF's Profit vs Risk Rating (85) in the null industry is in the same range as SNN (100) in the Medical Specialties industry. This means that SDMHF’s stock grew similarly to SNN’s over the last 12 months.

SDMHF's SMR Rating (82) in the null industry is in the same range as SNN (94) in the Medical Specialties industry. This means that SDMHF’s stock grew similarly to SNN’s over the last 12 months.

SDMHF's Price Growth Rating (53) in the null industry is in the same range as SNN (59) in the Medical Specialties industry. This means that SDMHF’s stock grew similarly to SNN’s over the last 12 months.

SDMHF's P/E Growth Rating (17) in the null industry is significantly better than the same rating for SNN (91) in the Medical Specialties industry. This means that SDMHF’s stock grew significantly faster than SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SDMHFSNN
RSI
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
55%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CTA28.970.44
+1.54%
Simplify Managed Futures Strategy ETF
HYLG23.64-0.36
-1.48%
Global X Health Care Cvrd Cll&Gr ETF
NULC47.53-0.75
-1.56%
Nuveen ESG Large-Cap ETF
KCCA19.36-0.33
-1.68%
KraneShares California Carbon Allw ETF
FLJP28.46-0.73
-2.50%
Franklin FTSE Japan ETF

SDMHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDMHF has been loosely correlated with SOAGY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDMHF jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDMHF
1D Price
Change %
SDMHF100%
N/A
SOAGY - SDMHF
44%
Loosely correlated
-2.34%
SRTOY - SDMHF
35%
Loosely correlated
-1.55%
JNDOF - SDMHF
30%
Poorly correlated
N/A
WAT - SDMHF
25%
Poorly correlated
-3.56%
SNN - SDMHF
24%
Poorly correlated
-2.16%
More

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with TFX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
-2.16%
TFX - SNN
58%
Loosely correlated
-3.15%
NSTM - SNN
43%
Loosely correlated
N/A
IDXX - SNN
43%
Loosely correlated
-3.82%
MDT - SNN
39%
Loosely correlated
-1.65%
SYK - SNN
38%
Loosely correlated
-3.14%
More